Dna XSONM
13F holders, Q1 2026 (March 31)9holders +1
3new positions
4sold out
$4.03avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Dna X Inc. (SONM) in their 13F filings, up 1 from Q4 2025. 3 opened new positions and 4 sold out. The largest holders were UBS Group AG ($146K), C2C Wealth Management, LLC ($81K) and Geode Capital Management, LLC ($60K).
- Company
- Dna X Inc.
- CUSIP
- 83548F408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $143K |
| Exits | 4 | $194K |
All 13F filers, Q4 2025 → Q1 2026: 63,000 shares bought and 61,631 shares sold, net +1,369 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| UBS Group AG | 0.00% | Add +317.2% | 36,219 | $146K |
| C2C Wealth Management, LLC | 0.07% | New | 20,000 | $81K |
| Geode Capital Management, LLC | 0.00% | New | 14,802 | $60K |
| BlackRock, Inc. | 0.00% | No change | 14,006 | $56K |
| Vanguard Capital Management LLC | 0.00% | — | 4,892 | $20K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 4,496 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 661 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 214 | $862 |
| Danske Bank A/S | 0.00% | No change | 4 | $16 |
"% of holder's portfolio" is SONM's weight in each manager's 13F, not the share of Dna X Inc. the manager owns.